Key statistics
On Friday, Travere Therapeutics Inc (TVTX:NMQ) closed at 27.82, -33.97% below its 52-week high of 42.13, set on Dec 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 30.60 |
|---|---|
| High | 31.44 |
| Low | 27.25 |
| Bid | 27.95 |
| Offer | 30.00 |
| Previous close | 30.60 |
| Average volume | 1.43m |
|---|---|
| Shares outstanding | 89.47m |
| Free float | 84.04m |
| P/E (TTM) | -- |
| Market cap | 2.49bn USD |
| EPS (TTM) | -1.08 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Travere Therapeutics to Participate at Upcoming Investor Conferences
- Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
